DGAP-News: 4TEEN4 Pharmaceuticals GmbH: Dipeptidyl peptidase 3 biomarker to drive precision medicine in COVID-19
Issuer: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Study 11.04.2022 / 11:00 The issuer is solely responsible for the content of this announcement. Dipeptidyl Peptidase 3 release is